APLS

Neutral

RTW Investments, Roderick Wong report 3.69M shares in Apellis (APLS)

RTW Investments, LP and Roderick Wong have filed an amended passive investment disclosure (Schedule 13G/A) for Apellis Pharmaceuticals, Inc. (APLS), r...

Stock Titan 3 weeks ago 0

Neutral

Apellis (APLS) HSR waiting period expired; $41.00 cash plus up to $4.00 CVR

Apellis Pharmaceuticals has announced that the Hart-Scott-Rodino (HSR) waiting period for its tender offer and merger has expired as of May 11, 2026, ...

Stock Titan 4 weeks ago 0